Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

GEM-230 in preclinical testing at Hybridon

Aug. 16, 1996

ISIS-3521/CGP-64128A efficacy shown in preclinical models

Aug. 16, 1996

MAM-102: antineoplastic protein tyrosine kinase inhibitor

Aug. 16, 1996

Letrozole approved for marketing in France

Aug. 16, 1996

Sanofi Winthrop discloses topoisomerase II inhibitors

Aug. 16, 1996

Guilford to develop anticancer drugs in biodegradable polymers

Aug. 16, 1996

SuperGen acquires marketing rights for Barr generic drugs

Aug. 16, 1996

SS Pharm. discloses antitumor platinum complexes

Aug. 16, 1996

NCI supports clinical testing of MGI-114

Aug. 16, 1996

NCI begins pediatric study of carboplatin/RMP-7 combination

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...